{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:12:55Z","timestamp":1758042775340,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR069583"],"award-info":[{"award-number":["AR069583"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bone.2021.116160","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T20:20:05Z","timestamp":1630182005000},"page":"116160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Chloroquine increases osteoclast activity in vitro but does not improve the osteopetrotic bone phenotype of ADO2 mice"],"prefix":"10.1016","volume":"153","author":[{"given":"Imranul","family":"Alam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita L.","family":"Gerard-O'Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dena","family":"Acton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara L.","family":"Hardman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Min","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Bruzzaniti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Econs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2021.116160_bb0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00005792-196803000-00004","article-title":"Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form","volume":"47","author":"Johnston","year":"1968","journal-title":"Medicine"},{"issue":"25","key":"10.1016\/j.bone.2021.116160_bb0010","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","article-title":"Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene","volume":"10","author":"Cleiren","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.bone.2021.116160_bb0015","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1359\/jbmr.2003.18.8.1513","article-title":"Chloride Channel 7 (CICN7) gene mutations and autosomal dominant osteopetrosis, type II","volume":"18","author":"Waguespack","year":"2003","journal-title":"JBMR"},{"issue":"3","key":"10.1016\/j.bone.2021.116160_bb0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jc.2006-1986","article-title":"Autosomal dominant Osteopetrosis: clinical severity and natural history of 94 subjects with Chloride Channel 7 (C1CN7) gene mutations","volume":"92","author":"Waguespack","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116160_bb0025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/bonekey.2014.15","article-title":"Osteopetrosis: pathogenesis, management and future directions for research","volume":"11","author":"Weber","year":"2014","journal-title":"IBMS BoneKey"},{"issue":"59C","key":"10.1016\/j.bone.2021.116160_bb0030","first-page":"66","article-title":"Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models","volume":"Nov 1","author":"Alam","year":"2013","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bone.2021.116160_bb0035","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1359\/jbmr.060409","article-title":"Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties","volume":"21","author":"Chu","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bone.2021.116160_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012585","article-title":"The G215R mutation in the Cl-\/H+-antiporter ClC-7 found in ADO II osteopetrosis does not abolish function but causes a severe trafficking defect","volume":"5","author":"Schulz","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bone.2021.116160_bb0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00223-008-9168-8","article-title":"Ion transporters involved in acidification of the resorption lacuna in osteoclasts","volume":"83","author":"Henriksen","year":"2008","journal-title":"Calcif. Tissue Int."},{"issue":"7","key":"10.1016\/j.bone.2021.116160_bb0050","doi-asserted-by":"crossref","first-page":"784","DOI":"10.15252\/embr.201438553","article-title":"Transport activity and presence of ClC-7\/Ostm1 complex account for different cellular functions","volume":"15","author":"Weinert","year":"2014","journal-title":"EMBO Rep."},{"issue":"11","key":"10.1016\/j.bone.2021.116160_bb0055","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/emboj.2011.137","article-title":"ClC-7 is a slowly voltage-gated 2Cl(\u2212)\/1H(+)-exchanger and requires Ostm1 for transport activity","volume":"30","author":"Leisle","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2021.116160_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","article-title":"Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man","volume":"104","author":"Kornak","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bone.2021.116160_bb0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature04535","article-title":"ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function","volume":"440","author":"Lange","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bone.2021.116160_bb0070","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.emboj.7600576","article-title":"Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration","volume":"24","author":"Kasper","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2021.116160_bb0075","first-page":"383","article-title":"Relative roles of collagenase and lysosomal cysteine-proteinases in bone resorption","volume":"1","author":"Vaes","year":"1992","journal-title":"Matrix Suppl."},{"issue":"9","key":"10.1016\/j.bone.2021.116160_bb0080","first-page":"1139","article-title":"The role of collagenase in bone resorption. An overview","volume":"36","author":"Eeckhout","year":"1988","journal-title":"Pathol Biol (Paris)."},{"issue":"294","key":"10.1016\/j.bone.2021.116160_bb0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00003086-199309000-00003","article-title":"Recent advances toward understanding osteoclast physiology","author":"Blair","year":"1993","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2021.116160_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.644503","article-title":"The mechanism switching the osteoclast from short to long duration bone resorption","volume":"9","author":"Delaisse","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.bone.2021.116160_bb0095","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1600-0854.2011.01292.x","article-title":"At the crossroads of chemistry and cell biology: inhibiting membrane traffic by small molecules","volume":"13","author":"von Kleist","year":"2012","journal-title":"Traffic"},{"issue":"5","key":"10.1016\/j.bone.2021.116160_bb0100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2492\/inflammregen.32.222","article-title":"Inhibitory effect of chloroquine on bone resorption reveals the key role of lysosomes in osteoclast differentiation and function","volume":"32","author":"Al-Bari","year":"2012","journal-title":"Inflamm. Regen."},{"issue":"2","key":"10.1016\/j.bone.2021.116160_bb0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4269\/ajtmh.1987.36.213","article-title":"The basis of antimalarial action: non-weak base effects of chloroquine on acid vesicle pH","volume":"36","author":"Krogstad","year":"1987","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"3","key":"10.1016\/j.bone.2021.116160_bb0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s004410050075","article-title":"Visualization of acidic compartments in cultured osteoclasts by use of an acidotrophic amine as a marker for low pH","volume":"298","author":"Inoue","year":"1999","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.bone.2021.116160_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.bone.2021.116160_bb0120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/BOR.0b013e32834456bf","article-title":"Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action","volume":"23","author":"Katz","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bone.2021.116160_bb0125","doi-asserted-by":"crossref","unstructured":"Nicoli ER, Weston MR, Hackbarth M, Becerril A, Larson A, Zein WM, Baker PR 2nd, Burke JD, Dorward H, Davids M, Huang Y, Adams DR, Zerfas PM, Chen D, Markello TC, Toro C, Wood T, Elliott G, Vu M; Undiagnosed Diseases Network, Zheng W, Garrett LJ, Tifft CJ, Gahl WA, Day-Salvatore DL, Mindell JA, Malicdan MCV. Lysosomal storage and albinism due to effects of a de novo CLCN7 variant on lysosomal acidification. Am. J. Hum. Genet. 2019 Jun 6;104(6):1127\u20131138.","DOI":"10.1016\/j.ajhg.2019.04.008"},{"key":"10.1016\/j.bone.2021.116160_bb0130","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1167\/iovs.10-5278","article-title":"Induction of lysosomal dilatation, arrested autophagy, and cell death by chloroquine in cultured ARPE-19 cells","volume":"51","author":"Yoon","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bone.2021.116160_bb0135","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy."},{"issue":"26","key":"10.1016\/j.bone.2021.116160_bb0140","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/bloodadvances.2017011304","article-title":"Osteomacs interact with megakaryocytes and osteoblasts to regulate murine hematopoietic stem cell function","volume":"1","author":"Mohamad","year":"2017","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.bone.2021.116160_bb0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res"},{"issue":"8","key":"10.1016\/j.bone.2021.116160_bb0150","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1128\/AAC.00067-11","article-title":"Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model","volume":"55","author":"Moore","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"24","key":"10.1016\/j.bone.2021.116160_bb0155","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.3390\/ijms21249352","article-title":"The inhibitory role of Rab11b in osteoclastogenesis through triggering lysosome-induced degradation of c-Fms and RANK surface receptors","volume":"21","author":"Tran","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bone.2021.116160_bb0160","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.3390\/cells9112384","article-title":"Rab11A functions as a negative regulator of osteoclastogenesis through dictating lysosome-induced proteolysis of c-fms and RANK surface receptors","volume":"9","author":"Okusha","year":"2020","journal-title":"Cells."},{"issue":"1","key":"10.1016\/j.bone.2021.116160_bb0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1172\/JCI66947","article-title":"Chloroquine reduces osteoclastogenesis in muring osteoporosis by preventing TRAF3 degradation","volume":"124","author":"Xiu","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bone.2021.116160_bb0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10753-019-01111-0","article-title":"Chloroquine and 3-methyladenine attenuates periodontal inflammation and bone loss in experimental periodontitis","volume":"43","author":"He","year":"2020","journal-title":"Inflammation."},{"issue":"18","key":"10.1016\/j.bone.2021.116160_bb0175","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.3390\/ijms21186971","article-title":"4-Acetylantroquinonol B inhibits osteoclastogenesis by inhibiting the autophagy pathway in a simulated microgravity model","volume":"21","author":"Wu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bone.2021.116160_bb0180","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1002\/jcp.29205","article-title":"Antiosteoclastic bone resorption activity of osteoprotegerin via enhanced AKT\/mTOR\/ULK1-mediated autophagic pathway","volume":"235","author":"Zhao","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.bone.2021.116160_bb0185","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.bbrc.2020.04.155","article-title":"Autophagy-dependent mitochondrial function regulates osteoclast differentiation and maturation","volume":"527","author":"Aoki","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2021.116160_bb0190","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.3389\/fimmu.2018.02263","article-title":"Bone remodeling and the role of TRAF3 in osteoclastic bone resorption","volume":"9","author":"Boyce","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bone.2021.116160_bb0195","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/jcp.26028","article-title":"Hydroxychloroquine affects bone resorption both in vitro and in vivo","volume":"233","author":"Both","year":"2018","journal-title":"J. Cell. Physiol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:02:37Z","timestamp":1757613757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221003264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"alternative-id":["S8756328221003264"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116160","relation":{},"ISSN":["8756-3282"],"issn-type":[{"type":"print","value":"8756-3282"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chloroquine increases osteoclast activity in vitro but does not improve the osteopetrotic bone phenotype of ADO2 mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116160"}}